Written and medically reviewed by Dr. Don Zone, MD, FACC, FAARM — Board-Certified Cardiologist
The supplement aisle has done something unhelpful with three sets of letters. NAD+, NMN, and NR all appear on bottles, often with identical promises, usually with no explanation of how they relate. Patients ask me which one to buy as if they were three competing brands. They aren’t. They’re three points on the same assembly line — and once you see the assembly line, the choice gets much simpler.
Here’s the plain-English version I give in my practice.
Now the longer version, because the details are where the buying decisions get smart.
First, What NAD+ Actually Is
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It has two day jobs. First, energy: NAD+ shuttles electrons in the reactions that turn your food into ATP — no NAD+, no cellular energy. Second, repair and regulation: it’s the fuel for sirtuins and PARP enzymes, which manage DNA repair and stress responses.
The reason anyone supplements around it: NAD+ levels decline substantially with age, and that decline is one of the better-documented biochemical signatures of aging. The strategy of raising NAD+ back up is the entire premise of this supplement category — we cover the background in our complete guide to NMN supplements and the longevity science glossary.
One clarification that saves confusion later: NADH is not a different supplement category — it’s the same molecule wearing its electron cargo. NAD+ is the “empty” form, NADH the “loaded” form; your cells cycle between the two constantly.
Why You Can’t Just Take NAD+
If NAD+ is what cells need, why not swallow NAD+? Because of how the molecule is built. NAD+ is large, charged, and unstable in the digestive tract — pharmacology reviews show that orally ingested NAD+ is broken down into smaller pieces (including nicotinamide and NR) before absorption, and laboratory work confirms that even extracellular NAD+ must be degraded into precursor fragments before cells can take it up and rebuild it inside.
So an “NAD+ supplement” taken by mouth is, at best, an expensive way of delivering the same building blocks that NMN and NR deliver directly — and at worst, a molecule your gut dismantles into ordinary vitamin B3 components. This is why the serious research effort has focused on the precursors. (IV NAD+ drips sidestep digestion, but that’s a clinical procedure with its own cost, time, and evidence questions — not a daily supplement strategy.)
The assembly line, in order: NR → NMN → NAD+. NR (nicotinamide riboside) is converted to NMN, and NMN (nicotinamide mononucleotide) is the final step before NAD+. Both feed the same “salvage pathway” your cells use to recycle and rebuild their NAD+ supply.
NMN vs NR: What Human Trials Show
Both precursors have real human data behind them. Here’s the honest scorecard, human randomized trials only.
Raising NAD+ — effectively a tie. In the first head-to-head randomized human trial, published in Nature Metabolism, 65 healthy adults took 1 g of NR, 1 g of NMN, plain nicotinamide, or placebo for 14 days. NR and NMN each roughly doubled whole-blood NAD+ versus placebo; plain nicotinamide didn’t move baseline levels at all. The authors’ conclusion: NR and NMN are comparable at raising NAD+. That result also tells you something useful about cheap “vitamin B3 raises NAD+ anyway” claims — the basic form didn’t do it.
NR’s evidence base. A 6-week crossover trial in healthy adults aged 55–79 found 1,000 mg/day of NR raised NAD+ in blood cells by about 60% and was well tolerated; blood-pressure improvements were exploratory trends, not confirmed findings. An 8-week dose-ranging study in 140 overweight adults found NAD+ rose dose-dependently — about 22% at 100 mg, 51% at 300 mg, and 142% at 1,000 mg — with a clean safety profile. NR’s paper trail is strongest on safety and dosing.
NMN’s evidence base. NMN has more trials measuring functional outcomes, particularly in older adults. A 60-day dose-comparison trial (300/600/900 mg) found NAD+ and six-minute-walk distance improved at every dose, with benefits peaking at 600 mg. A 12-week trial in men over 65 found 250 mg/day raised NAD+ with nominally significant gains in gait speed and grip strength. A trial in trained runners found dose-dependent improvements in oxygen utilization. We walk through all of it in our NMN dosage guide.
The fair summary of the comparison:
| Question | NMN | NR |
|---|---|---|
| Raises blood NAD+ | Yes (~2× at 1 g in head-to-head) | Yes (~2× at 1 g in head-to-head) |
| Functional outcomes in older adults | Walking distance, gait speed, grip strength in RCTs | Mostly biomarker endpoints; functional findings exploratory |
| Dose-response mapped | 300–900 mg (benefit peaked ~600 mg) | 100–1,000 mg (NAD+ rose with dose) |
| Safety record in trials | Good to 1,250 mg short-term | Good to 1,000 mg over 8 weeks |
| Regulatory status (US) | Confirmed a lawful dietary ingredient, Sept 2025 | Lawful; NR has established NDI history |
Neither molecule “wins” this table. They’re adjacent steps on one pathway, they perform comparably at the shared endpoint, and each has trial coverage the other lacks.
So Which Should You Take?
My framework, by goal:
- General NAD+ support, healthy aging focus: either precursor is defensible; NMN is the one with randomized-trial evidence on physical function in the 60+ age group, which is why it’s my default in that population.
- You care most about the longest safety/dosing paper trail: NR’s dose-ranging and safety data are excellent. A reasonable choice, particularly if NMN doesn’t agree with you.
- You’re deciding between doses, not molecules: the evidence supports moderate daily doses — 250–600 mg NMN or 300–1,000 mg NR — taken consistently for 8–12 weeks before judging. Megadosing has no demonstrated advantage in the general population.
- You’re tempted by “NAD+ direct” capsules: skip them. You’d be paying a premium for a molecule your digestion disassembles into what the precursors already are.
- Taking both NMN and NR: not harmful, but redundant — they feed the same pathway. An adequate dose of one beats token doses of two. Our NMN vs NR deep-dive covers this pairing question in more detail.
And one principle above all of them: a precursor raises NAD+; it doesn’t run the rest of your energy metabolism. NAD+ carries electrons to the mitochondrial machinery — it doesn’t replace the CoQ10 in the electron transport chain, the B-vitamin cofactors throughout the pathway, or the magnesium that ATP itself needs to function. That’s the reasoning behind Longevion™: I paired 300 mg of NMN — inside the best-evidenced dose range — with 150 mg of CoQ10, methylated B vitamins, and magnesium malate, so the NAD+ raw material arrives alongside the machinery that uses it. One capsule of a precursor alone answers only one question on this page. You can compare the full lineup on our NAD+ and NMN supplements page.
Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before beginning any supplement, particularly if you take prescription medication, are pregnant or nursing, or have a medical condition. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.